tesamorelin
6 articles tagged with ‘tesamorelin’
Tesamorelin vs Ipamorelin: Human Evidence, Doses, Safety
Tesamorelin holds FDA approval for HIV-associated lipodystrophy; ipamorelin has none. This page maps the published human dosing data for each and marks the gaps.
Tesamorelin vs CJC-1295: Evidence Gaps and Data
No head-to-head trial compares tesamorelin and CJC-1295. Existing evidence is analytical, not clinical, leaving efficacy claims unsupported.
Tesamorelin vs Ipamorelin: Evidence, Uses, Risks
This article compares tesamorelin and ipamorelin based on published human evidence, highlighting what is known about their uses and risks and where direct comparative data is missing.
Tesamorelin vs Sermorelin: Comparing GHRH Analogues in Research
Compare tesamorelin vs sermorelin GHRH analogues for research. Explore mechanisms, preclinical findings, and evidence limitations.
Tesamorelin: Mechanism of Action, Clinical Evidence, and Research Applications
Explore tesamorelin's mechanism, clinical evidence, and preclinical research applications for growth hormone-releasing hormone agonism.
Harnessing Peptides for Metabolic Health: Advances in Diabetes and Obesity Research
Explore the research potential of peptides for metabolic health, including diabetes and obesity. A review of preclinical evidence and safety.